The future of heart and lung transplantation: Insights from Dr. Andrew Lodge - London Business News | Londonlovesbusiness.com
Briefly

Organ transplantation has revolutionized medicine, particularly in treating terminal lung and heart diseases. Dr. Andrew James Lodge highlights the increasing number of procedures and the ongoing organ shortage crisis. While over 4,100 heart and nearly 2,700 lung transplants were performed in the U.S. in 2022, the demand for donor organs surpasses availability. Innovations like ex vivo lung perfusion (EVLP) allow better organ preservation, extending the time for transplantation and enhancing patient outcomes.
The need for donor organs far exceeds availability. That's one of the biggest hurdles we face in transplantation today. Technology and innovation are key to addressing this problem and improving patient outcomes.
Traditionally, hearts and lungs were to be transplanted in a very short time frame. With advanced preservation technology, we have more time to get organs to patients, thereby helping us to transplant more people.
Read at London Business News | Londonlovesbusiness.com
[
|
]